Global Clinical Trial Drug Sourcing Market Growth (Status and Outlook) 2024-2030

Global Clinical Trial Drug Sourcing Market Growth (Status and Outlook) 2024-2030

Clinical Trial Drug Sourcing refers to the specialized services provided by enterprises or organizations to facilitate the procurement, management and distribution of clinical trial investigation drugs and related supplies. These services help streamline the drug procurement process, reduce risk and ensure compliance with regulatory requirements, and are critical to ensuring researchers have access to the necessary drugs and materials they need to conduct their studies effectively and safely.

The global Clinical Trial Drug Sourcing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Clinical Trial Drug Sourcing Industry Forecast” looks at past sales and reviews total world Clinical Trial Drug Sourcing sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Trial Drug Sourcing sales for 2023 through 2029. With Clinical Trial Drug Sourcing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Drug Sourcing industry.

This Insight Report provides a comprehensive analysis of the global Clinical Trial Drug Sourcing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial Drug Sourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Trial Drug Sourcing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Drug Sourcing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Drug Sourcing.

United States market for Clinical Trial Drug Sourcing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Clinical Trial Drug Sourcing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Clinical Trial Drug Sourcing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Clinical Trial Drug Sourcing players cover Patheon (Thermo Fisher Scientific), McKesson, Sharp Services, Almac Group, Myonex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Drug Sourcing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Direct Sourcing
Open Market Sourcing

Segmentation by Application:
CRO
Biotech Firms
Research Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Direct Sourcing
Open Market Sourcing

Segmentation by Application:
CRO
Biotech Firms
Research Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Patheon (Thermo Fisher Scientific)
McKesson
Sharp Services
Almac Group
Myonex
Clinigen
Clinical Services International (CSI)
Cencora
Euromed Pharma
ICON
RxSource
Bionic Emas
IQVIA
WEP Clinical
EarlyHealth Group
Catalent
Inceptua
NewLife Medicals
Yourway
BMclinical (BModesto)
Firstline Pharma
ClientPharma
Tanner Pharma
Alcura Health
Midwest Pharmaceuticals
ADAllen Pharma
Neunco
Jean Standard Biological
Memorial Pharmaceutical
Clinschain

Please note: The report will take approximately 2 business days to prepare and deliver.